Financial services firm Cantor Fitzgerald expanded its Healthcare Equity Research team by adding senior research analysts Bill Tanner to cover biotechnology and Steven Halper to cover Healthcare Services.

Both Tanner and Halper are managing directors based in New York.

“With the continued growth and innovation in the healthcare and biotech sectors, Cantor Fitzgerald is further expanding its thought-leadership presence and providing value for clients in these complex and dynamic sectors,” said Shawn Matthews, CEO of Cantor Fitzgerald.

Tanner joined the firm from Guggenheim Securities, where he was a senior biotechnology analyst. Prior to Guggenheim, Tanner was at Lazard Capital Markets, Leerink Swann and SG Cowen.

Prior to joining Cantor Fitzgerald, Halper focused on healthcare information technology, managed care and pharmaceutical service industries at several major firms including FBR Capital Markets and Lazard Capital Markets. Previously, Halper served for two years in this capacity at Stifel Financial and for 10 years at Thomas Weisel Partners.